Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 1;203(1):13-7.
doi: 10.1093/infdis/jiq005.

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010

Affiliations

Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010

Tiffany G Sheu et al. J Infect Dis. .

Abstract

Two distinct genetic clades of seasonal influenza A(H1N1) viruses have cocirculated in the recent seasons: clade 2B oseltamivir-resistant and adamantane-susceptible viruses, and clade 2C viruses that are resistant to adamantanes and susceptible to oseltamivir. We tested seasonal influenza A(H1N1) viruses collected in 2008-2010 from the United States and globally for resistance to antivirals approved by the Food and Drug Administration. We report 28 viruses with both adamantane and oseltamivir (dual) resistance from 5 countries belonging to 4 distinct genotypes. Because of limited options for antiviral treatment, emergence of dual-resistant influenza viruses poses a public health concern, and their circulation needs to be closely monitored.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Summary of genotypes of dual-resistant seasonal influenza A(H1N1) viruses detected by full genome analysis, 2008–2010. Clade 2B genes are indicated by blue rectangles, and clade 2C genes are indicated by green rectangles. Oseltamivir resistance is indicated by a red solid outline. Adamantane resistance in the clade 2B M gene is indicated by a red dashed outline. Adamantane resistance in the clade 2C M gene is indicated by a red dotted outline. Reassortant genotypes are indicated by the bracket.

Comment in

References

    1. Hay AJ, Zambon MC, Wolstenholme AJ, Skehel JJ, Smith MH. Molecular basis of resistance of influenza A viruses to amantadine. J Antimicrob Chemother. 1986;18( Suppl B):19–29. - PubMed
    1. Belshe RB, Smith MH, Hall CB, Betts R, Hay AJ. Genetic Basis of Resistance to Rimantadine Emerging during Treatment of Influenza Virus Infection. J Virol. 1988;62(5):1508–1512. - PMC - PubMed
    1. Deyde VM, Gubareva LV. Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Rev Mol Diagn. 2009;9(5):493–509. - PubMed
    1. Barr IG, Deng YM, Iannello P, Hurt AC, Komadina N. Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antivir Res. 2008;80:200–205. - PubMed
    1. Sheu TG, Deyde VM, Okomo-Adhiambo M, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother. 2008;52:3284–3292. - PMC - PubMed

Publication types

MeSH terms